Cargando…

Cell-free and concentrated ascites reinfusion therapy for refractory massive cardiac ascites in an adult with single ventricle haemodynamics: a case report

BACKGROUND: Cardiac ascites is a classical finding of right-sided heart failure, mainly caused by tricuspid valve disease and constrictive pericarditis. Refractory cardiac ascites, defined as ascites that is uncontrollable with any medication, including conventional diuretics and selective vasopress...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsukishiro, Yasue, Yamamoto, Hiroyuki, Masumoto, Akiko, Takaya, Tomofumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991052/ https://www.ncbi.nlm.nih.gov/pubmed/36895305 http://dx.doi.org/10.1093/ehjcr/ytad081

Ejemplares similares

Reinfusion of ascites during hemodialysis as a treatment of massive refractory ascites and acute renal failure
por: Hsu, Ta-Wei, et al.
Publicado: (2011)

Weaning from concentrated ascites reinfusion therapy for refractory ascites by SGLT2 inhibitor
por: Miyamoto, Yasunori, et al.
Publicado: (2021)

Cell-free and Concentrated Ascites Reinfusion Therapy for Refractory Ascites in Cirrhosis in Post-marketing Surveillance and the Role of Tolvaptan
por: Iwasa, Motoh, et al.
Publicado: (2019)

Ultrastructural observation of filtration membrane in cell‐free and concentrated ascites reinfusion therapy for malignant ascites
por: Koga, Kenichi, et al.
Publicado: (2021)

Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in refractory ascites: Post-marketing surveillance results
por: Hanafusa, Norio, et al.
Publicado: (2017)

Cell-Free and Concentrated Ascites Reinfusion Therapy during Hemodialysis for Intradialytic Hypotension and Intractable Ascites
por: Hayasaka, Hideyuki, et al.
Publicado: (2022)

Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experience
por: Tsubokura, Misato, et al.
Publicado: (2022)

Feasibility of a fast-track randomized controlled trial of cell-free and concentrated ascites reinfusion therapy for patients with refractory malignant ascites
por: Yokomichi, Naosuke, et al.
Publicado: (2022)

Proliferative Glomerulonephritis with Monoclonal IgG Deposits and Refractory Ascites: Successful Treatment with Rituximab and Cell-free and Concentrated Ascites Reinfusion Therapy
por: Takami, Norito, et al.
Publicado: (2022)

A Case of Cell-Free and Concentrated Ascites Reinfusion Therapy Effective for Refractory Ascites in Spontaneous Bacterial Peritonitis in a Renal Transplant Patient
por: Maeda, Atsuhiro, et al.
Publicado: (2012)

Ascites reinfusion dialysis of refractory ascites as a bridge to kidney and liver transplantation in a patient on hemodialysis
por: Chang, Kyung Yoon, et al.
Publicado: (2017)

Effectiveness of Cell-Free and Concentrated Ascites Reinfusion Therapy in the Treatment of Malignancy-Related Ascites: A Systematic Review and Meta-Analysis
por: Chen, Hao, et al.
Publicado: (2021)

Verification of serum albumin elevating effect of cell-free and concentrated ascites reinfusion therapy for ascites patients: a retrospective controlled cohort study
por: Yamada, Yosuke, et al.
Publicado: (2019)

Development of a novel automatic ascites filtration and concentration equipment with multi‐ring‐type roller pump units for cell‐free and concentrated ascites reinfusion therapy
por: Okahisa, Toshiya, et al.
Publicado: (2020)

Encapsulating peritoneal sclerosis caused by cell-free and concentrated ascites reinfusion therapy: a case report
por: Itagaki, Hideya, et al.
Publicado: (2021)

Ascites management by cell-free concentrated ascites reinfusion therapy during recovery from drug-induced acute liver injury: a case report
por: Yasuda, Koya, et al.
Publicado: (2020)

Eradication of intractable malignant ascites by abdominocentesis, reinfusion of concentrated ascites, and adoptive immunotherapy with dendritic cells and activated killer cells in a patient with recurrent lung cancer: a case report
por: Kimura, Hideki, et al.
Publicado: (2008)

Ascites, refractory ascites and hyponatremia in cirrhosis
por: Fortune, Brett, et al.
Publicado: (2017)

Successful treatment of systemic AL amyloidosis with autologous hematopoietic stem cell transplantation combined with cell‐free and concentrated ascites reinfusion therapy
por: Oka, Satoko, et al.
Publicado: (2023)

Rituximab pharmacokinetics in ascites and serum in the treatment of follicular lymphoma with massive ascites
por: Hiroshima, Yuki, et al.
Publicado: (2012)

Refractory Massive Ascites: An Unusual Presentation of Nephrogenic Diabetes Insipidus
por: Pezantes, María Ignacia, et al.
Publicado: (2021)

Management of refractory cirrhotic ascites: challenges and solutions
por: Fukui, Hiroshi, et al.
Publicado: (2018)

Refractory Chylous Ascites
por: Soto, Rodrigo, et al.
Publicado: (2008)

Management of refractory ascites
por: Wong, Florence
Publicado: (2023)

Evaluation of the performance, operability, and safety of Plasauto μ, a new type of machine for cell‐free and concentrated ascites reinfusion therapy, in a postmarketing clinical study
por: Hasegawa, Midori, et al.
Publicado: (2021)

Investigation of Endotoxin Positivity in Ascites at the Time of Cell-free and Concentrated Ascites Re-infusion Therapy
por: Ohara, Takateru, et al.
Publicado: (2023)

Tolvaptan for the Treatment of Refractory Ascites
por: Kurosaki, Masayuki, et al.
Publicado: (2016)

Oxaliplatin-related Portal Hypertension Complicated with Esophageal Varices and Refractory Massive Ascites
por: Yazaki, Tomotaka, et al.
Publicado: (2022)

Treatment of refractory ascites with an automated low‐flow ascites pump in patients with cirrhosis
por: Stirnimann, G., et al.
Publicado: (2017)

Effective recovery of highly purified CD326(+) tumor cells from lavage fluid of patients treated with a novel cell-free and concentrated ascites reinfusion therapy (KM-CART)
por: Kimura, Yukino, et al.
Publicado: (2015)

Clinical Features of Refractory Ascites in Outpatients
por: Caly, Wanda Regina, et al.
Publicado: (2017)

Hereditary Hemorrhagic Telangiectasia and Refractory Ascites
por: Thandassery, Ragesh B., et al.
Publicado: (2020)

Massive Elevation of CA-125 in Chylous Ascites
por: Orbay, Tuğçe Merve, et al.
Publicado: (2023)

Ascitic Fluid Analysis in the Differential Diagnosis of Ascites: Focus on Cirrhotic Ascites
por: Huang, Lin-Lin, et al.
Publicado: (2014)

A case of chronic lymphocytic leukemia with massive ascites
por: Yonal, Ipek, et al.
Publicado: (2012)

Constrictive Pericarditis as a Cause of Refractory Ascites
por: Lominadze, Zurabi, et al.
Publicado: (2015)

Current management of refractory ascites in patients with cirrhosis
por: Zhao, Ruihong, et al.
Publicado: (2017)

Refractory ascites—the contemporary view on pathogenesis and therapy
por: Kasztelan-Szczerbinska, Beata, et al.
Publicado: (2019)

Radiological insertion of automated low flow ascitic pump (alfapump(®)) system for management of medically refractory ascites
por: Karkhanis, Salil, et al.
Publicado: (2017)

Comment on ‘Ascitic Fluid Analysis in the Differential Diagnosis of Ascites: Focus on Cirrhotic Ascites’
por: Ahmed, Furqan
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bfb9pfurt3777qjjoe8aiusstc